Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genome-wide significance for a modifier of age at neurological onset in Huntington's Disease at 6q23-24: the HD MAPS study

Autor: Gillis Tammy, Mysore Jayalakshmi, Djoussé Luc, Xu Gang, Prakash Ranjana, Wheeler Vanessa C, Lazzarini Alice, Ashizawa Tetsuo, Jones Randi, Paulsen Jane S, Frontali Marina, Novelletto Andrea, McCusker Elizabeth, Trent Ronald JA, Klimek Mary, Suchowersky Oksana, García Carmen, Gómez-Tortosa Estrella, Frati Luigi, Squitieri Ferdinando, Rosenblatt Adam, Margolis Russell L, Ross Christopher A, Nance Martha, Morrison Patrick J, Durr Alexandra, Warby Simon C, Hayden Michael R, Li Jian-Liang, Hakky Michael, Cupples L Adrienne, Saint-Hilaire Marie H, Cha Jang-Ho J, Hersch Steven M, Penney John B, Harrison Madaline B, Perlman Susan L, Zanko Andrea, Abramson Ruth K, Lechich Anthony J, Duckett Ayana, Marder Karen, Conneally P Michael, Gusella James F, MacDonald Marcy E, Myers Richard H

Publikováno v: BMC Medical Genetics, Vol 7, Iss 1, p 71 (2006)

Abstract Background Age at onset of Huntington's disease (HD) is correlated with the size of the abnormal CAG repeat expansion in the HD gene; however, several studies have indicated that other genetic factors also contribute to the variability in HD

Externí odkaz: https://doaj.org/article/e3f085610415408f8f263d3a98bea8fe

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Autor: Dueck AC; Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona., Mendoza TR; Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston., Mitchell SA; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland., Reeve BB; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill., Castro KM; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland., Rogak LJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Atkinson TM; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Bennett AV; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill., Denicoff AM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland., O'Mara AM; Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland., Li Y; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York., Clauser SB; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland., Bryant DM; Department of Clinical Research, Cancer Program of Our Lady of the Lake and Mary Bird Perkins, Baton Rouge, Louisiana., Bearden JD 3rd; Gibbs Cancer Center and Research Institute, Spartanburg, South Carolina., Gillis TA; Helen F. Graham Cancer Center and Research Institute, Christiana Care Health System, Newark, Delaware., Harness JK; Center for Cancer Prevention and Treatment, St. Joseph Hospital of Orange, Orange, California., Siegel RD; Helen and Harry Gray Cancer Center, Hartford Hospital, Hartford, Connecticut., Paul DB; patient advocate and cancer survivor, Brooklyn, New York., Cleeland CS; Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston., Schrag D; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Sloan JA; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Abernethy AP; Department of Medicine, Duke University Medical Center, Durham, North Carolina., Bruner DW; Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia., Minasian LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland., Basch E; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill5Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: JAMA oncology [JAMA Oncol] 2015 Nov; Vol. 1 (8), pp. 1051-9.